The world's first bivalent mRNA vaccine candidate against respiratory syncytial virus, or RSV, kicked off Phase I clinical ...

The holidays are fast approaching along with cooler weather and various respiratory illnesses. Here's when to get your ...

Shawn Johnson East started stressing as soon as she found out when her third child was due: smack-dab in the middle of ...

Getting the one-dose RSV vaccine is one of the easiest ways to do so ... year from RSV and the state of Oklahoma saw a ...

Cassandra Archer, MD, FACP, FAAP, is director of community health services at the Cayuga County Health Department. For more ...

The number of COVID cases increased last week to 146. Cases had been falling in April and May and were as low as 31 at the ...

For adults aged 60 years or older, RSV vaccination is effective for preventing associated hospitalizations and ED encounters.

The CDC recommends a single dose of any FDA-approved respiratory syncytial virus (RSV) vaccine for all adults ages 75 years ...

Regarding hospitalizations among immunocompetent older adults, vaccine effectiveness was 83% for the GSK vaccine and 73% for ...

The other group at the highest risk when it comes to RSV is children under age five, and specifically infants—especially ...

mRESVIA is the only RSV vaccine available in a pre-filled syringe ... Factors" in Moderna's Annual Report on Form 10-K for the fiscal year ended December 31, 2023 and in subsequent filings made by ...

Q3 results confirms that the U.S. vaccine market for respiratory syncytial virus (RSV), led by Pfizer (PFE) and GSK (GSK), is ...